共 50 条
- [1] Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeJAMA NEUROLOGY, 2015, 72 (09) : 1029 - 1042Sutphen, Courtney L.Jasielec, Mateusz S.Shah, Aarti R.Macy, Elizabeth M.Xiong, ChengjieVlassenko, Andrei G.Benzinger, Tammie L. S.Stoops, Erik E. J.Vanderstichele, Hugo M. J.Brix, BrittaDarby, Heather D.Vandijck, Manu L. J.Ladenson, Jack H.Morris, John C.Holtzman, David M.Fagan, Anne M.
- [2] Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's diseaseJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (01): : 83 - 86Barba, LorenzoAbu Rumeileh, SamirBellomo, GiovanniPaoletti, Federico PaoliniHalbgebauer, SteffenOeckl, PatrickSteinacker, PetraMassa, FedericoGaetani, LorenzoParnetti, LucillaOtto, Markus
- [3] Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthoodALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)Pettigrew, CorinneSoldan, AnjaWang, JiangxiaWang, Mei-ChengGreenberg, BarryAlbert, MarilynMoghekar, Abhay
- [4] Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's DiseaseJOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1085 - 1096Gomar, Jesus J.Conejero-Goldberg, ConcepcionDavies, PeterGoldberg, Terry E.
- [5] Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's diseaseALZHEIMERS & DEMENTIA, 2019, 15 (09) : 1149 - 1159Bos, IsabelleVos, Stephanie J. B.Schindler, Suzanne E.Hassenstab, JasonXiong, ChengjieGrant, ElizabethVerhey, FransMorris, John C.Visser, Pieter JelleFagan, Anne M.
- [6] Altered cerebrospinal fluid lipids in preclinical Alzheimer's diseaseFASEB JOURNAL, 2014, 28 (01):Fonteh, AlfredChiang, JiarongCipolla, MatthewHarrington, Michael
- [7] Longitudinal blood biomarker trajectories in preclinical Alzheimer's diseaseALZHEIMERS & DEMENTIA, 2023, : 5620 - 5631Yakoub, Yara J.Ashton, NicholasStrikwerda-Brown, CherieMontoliu-Gaya, Laia K.Karikari, ThomasKac, Przemyslaw R.Gonzalez-Ortiz, FernandoGallego-Rudolf, JonathanMeyer, Pierre-FrancoisSt-Onge, FredericSchoell, MichaelSoucy, Jean-PaulBreitner, John C. S.Zetterberg, HenrikBlennow, KajPoirier, JudesVilleneuve, Sylvia
- [8] Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyALZHEIMERS & DEMENTIA, 2019, 15 (06) : 742 - 753Lleo, AlbertoAlcolea, DanielMartinez-Lage, PabloScheltens, PhilipParnetti, LucillaPoirier, JudesSimonsen, Anja H.Verbeek, Marcel M.Rosa-Neto, PedroSlot, Rosalinde E. R.Tainta, MikelIzaguirre, AndreaReijs, Babette L. R.Farotti, LuciaTsolaki, MagdaVandenbergue, RikFreund-Levi, YvonneVerhey, Frans R. J.Clarimon, JordiFortea, JuanFrolich, LutzSantana, IsabelLuis Molinuevo, JoseLehmann, SylvainVisser, Pieter J.Teunissen, Charlotte E.Zetterberg, HenrikBlennow, Kaj
- [9] β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's diseasePEPTIDES, 2002, 23 (07) : 1205 - 1214Andreasen, NBlennow, K
- [10] Recent cerebrospinal fluid biomarker studies of Alzheimer's diseaseEXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 919 - 926Choi, Yong SeokChoe, Leila H.Lee, Kelvin H.